Sponsor Pipeline

ImmuneOnco Biopharmaceuticals (Shanghai) Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
10
Active Trials
4
Recruiting
4
Phase 3
6
Disease Areas
Active Trials by Phase
Phase 3
3
Phase 2/3
1
Phase 2
2
Phase 1/2
1
Phase 1
2
Early Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06647862 IMM01+Azacitidine VS Placebo +Azacitidine in Patients With Newly Diagnosed Chronic… Chronic Myelomonocytic Leukemia Recruiting
NCT06465446 A Study of IMM01 Plus Tiselizumab Versus Physician's Choice Chemotherapy in… Classic Hodgkin Lymphoma Not Yet Recruiting
NCT07355283 IMM0306 in Combination With Lenalidomide vs Placebo in Combination With Lenalidomide in… Relapsed/Refractory Follicular Lymphoma Not Yet Recruiting
Phase 2/3
NCT07621939 A Study of IMM0306 in IgG4-Related Disease IgG4-Related Disease Not Yet Recruiting
Phase 2
NCT06746870 A Phase II Clinical Study to Evaluate the Safety, Pharmacokinetic Profile, and… NSCLC Not Yet Recruiting
NCT07687914 A Study of IMM2510 + IMM27M Combination Therapy in Patients With Advanced Hepatocellular… HCC - Hepatocellular Carcinoma Not Yet Recruiting
Phase 1/2
NCT07170787 A Study of IMM2510 + IMM01 Combination Therapy in Patients With Advanced Solid Tumors Advanced Solid Tumors Not Yet Recruiting
Phase 1
NCT06764836 A Study of IMM2510 + IMM27M Combination Therapy in Patients With Advanced Solid Tumors Advanced Solid Tumors Recruiting
NCT07118085 A Randomized, Double-blind, Placebo-controlled, Single and Multiple Dose Escalation Phase… Healthy Postmenopausal Women Recruiting
Early Phase 1
NCT06788431 A Clinical Study of IMC-001 for Injection in Improving Atherosclerotic Plaque Stability… Atherosclerosis Recruiting
Disease Areas
Get alerts when ImmuneOnco Biopharmaceuticals (Shanghai) Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free